Halley E. Gilbert - 31 May 2023 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Director
Signature
/s/ Scott Burrows, as Attorney-in-Fact for Halley Gilbert
Issuer symbol
ARQT
Transactions as of
31 May 2023
Net transactions value
$0
Form type
4
Filing time
02 Jun 2023, 19:08:02 UTC
Previous filing
17 Jun 2022
Next filing
15 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARQT Common Stock Award $0 +4,375 +101% $0.000000 8,687 31 May 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARQT Stock Option (right to buy) Award $0 +12,220 $0.000000 12,220 31 May 2023 Common Stock 12,220 $7.51 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.
F2 The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023.